Wegovy (semaglutide) is approved for adults with weight problems with at least one medical condition, such as high blood pressure, type 2 diabetes, or high cholesterol.
Approved by the FDA, Wegovy works by mimicking a hormone called GLP-1 that targets areas of the brain that regulate appetite and food intake. It helps a person feel full for longer, prompting them to eat less. It also slows stomach emptying to promote fullness. Want to know more about Wegovy injections and their effectiveness for weight loss? Go to our Hormone Replacement Therapy LA website. Need to call us? Call us at 424-283-4273.
Wegovy contains the active drug semaglutide, which belongs to a class of medications called GLP-1 receptor agonists. GLP-1 stands for glucagon-like peptide-1, which is a hormone released naturally in the body after eating [1].
In a clinical study, people taking Wegovy lost 5-20% of their body weight on average over 68 weeks when used along with diet and exercise [2]. Like other weight loss medications, it’s meant to be used along with lifestyle changes.
Reduces Glucagon Secretion: It also reduces the secretion of glucagon after meals, which helps prevent the liver from producing too much sugar.
Hormone Replacement Therapy Consult $450
Wegovy has been shown to be quite effective for weight loss in clinical trials, leading to significant reductions in body weight and offering other health benefits. Here are some study results:
In a study involving 1,961 adults, it was found that users of Wegovy experienced significant weight loss. On average, they shed 15% of their body weight over a period of 68 weeks. In contrast, those who were given a placebo only lost about 2% of their body weight. Furthermore, 84% of Wegovy users achieved a weight loss of at least 5%, a stark contrast to the 31% in the placebo group.
In the second study, which included 611 adults receiving counseling, Wegovy users saw an impressive average weight loss of 16% after 68 weeks. In comparison, those given a placebo reported an average weight loss of 6%. Notably, 85% of individuals on Wegovy achieved a minimum weight loss of 5%, which was significantly higher than the 48% who did so with a placebo, demonstrating Wegovy’s substantial impact on weight loss.
In the third study of 902 adults who were maintaining their weight loss, those on Wegovy continued to slim down, achieving an additional 8% reduction in body weight over an extended 48 weeks. Conversely, placebo users experienced a weight rebound, regaining 7% of their body weight after discontinuing Wegovy. This suggests that ongoing Wegovy treatment may be necessary to prevent weight regain.
In a study with 1,210 adults diagnosed with type 2 diabetes, participants using Wegovy lost an average of 10% of their body weight over 68 weeks. Those in the placebo group saw a more modest weight loss of about 3%. Additionally, 67% of the Wegovy group achieved at least a 5% weight loss, which was more than double the 30% success rate seen in the placebo group, underscoring the potential benefits of Wegovy for weight management in diabetic patients.
In an adolescent study with 200 young participants aged between 12 and 18 years, Wegovy treatment led to an average BMI reduction of 16% over 68 weeks [3]. In stark contrast, those on a placebo saw their BMI increase by less than 1%. Moreover, approximately 73% of the adolescents using Wegovy successfully lost at least 5% of their body weight, compared to only about 18% of those taking a placebo, indicating a significant benefit of Wegovy in this age group.
Semaglutide is the key component of Wegovy, functioning as a GLP-1 receptor agonist, a mechanism it shares with Ozempic. Although both medications contain semaglutide, Ozempic is tailored for managing blood sugar levels in type 2 diabetes, not for weight loss. Wegovy stands out with its higher dosage of semaglutide at 2.4 mg, compared to Ozempic’s 1 mg. Studies comparing the two indicate that Wegovy’s higher dose more effectively curbs hunger and reduces calorie intake, leading to almost twice the weight loss seen with Ozempic.
Saxenda and Wegovy are both weekly injectable GLP-1 receptor agonists used for weight management, but they differ in their active ingredients; Saxenda contains liraglutide, while Wegovy has semaglutide. Clinical trials have shown that Wegovy users typically experience a weight reduction of about 15% from their initial weight after one year, compared to an average of 6% weight loss for those on Saxenda. This data suggests that Wegovy may offer superior weight loss results.
Orlistat, an oral medication taken with meals up to three times daily, operates differently from GLP-1 drugs like Wegovy. It acts in the gastrointestinal tract to inhibit the absorption of some fats from the diet. Although Orlistat is effective for certain individuals, research indicates that only about 10% of users achieve a weight loss of 10% or greater. In comparison, Wegovy has shown that almost 70% of its users can reach or exceed this level of weight loss when used over an extended period.
If you have health insurance through your employer or a private provider, you might be eligible to get Wegovy at no cost. Novo Nordisk offers a savings card that can reduce your monthly expenses by up to $225 if your insurance covers the medication.
For those without Wegovy insurance coverage, the cost can range from $1,350 to $1,800 for a 28-day supply. However, Novo Nordisk provides a savings card that could lower the cost by up to $500. With this card, eligible individuals may pay nothing for their monthly supply for up to 12 refills. It’s always best to check with your insurance provider and Novo Nordisk for the most accurate and current information regarding coverage and costs.
Weight Loss Clinic LA offers the best Wegovy Injections near me in Beverly Hills but can also come to your home or office throughout the Los Angeles area. We serve patients near Beverly Hills, Bel Air, West Hollywood, Santa Monica, West Los Angeles, Culver City, Hollywood, Venice, Marina del Rey, Malibu, Manhattan Beach, Redondo Beach, Downtown Los Angeles, Encino, Woodland Hills, Sherman Oaks, Calabasas, Burbank, Glendale, Hidden Hills, Agoura Hills, Northridge, North Hollywood, Topanga, Canoga Park, Reseda, Valley Glen, Chatsworth, West Hills, Winnetka, Universal City, Silverlake, Echo Park, and many more.
Hormone Replacement Therapy Consult $450
1 Year Testosterone Replacement Program $3200
Includes
We help startups in facilitating the development of disruptive te
When men begin testosterone replacement therapy (TRT), enhanced sexual performance and desire typically top their list of anticipated benefits. After all, testosterone is widely known
That sudden, sharp pain in your chest can be terrifying. Your mind immediately races to the worst-case scenario—heart attack. But for many women navigating the
Hormone Replacement Therapy (HRT) is increasingly recognized for its potential benefits in managing a myriad of age-related symptoms in both men and women. In a
Highly trained and honored my the medical community, Dr. David Nazarian is certified by the American Board of Internal Medicine and trained in Anti Aging medicine and Bio Identical hormone replacement therapy. He implements the most advanced, state-of-the-art technology and treatment options. Dr. Nazarian specializes in bio-identical hormone replacement therapy in men & women. He has extensive training and knowledge in treating andropause and testosterone replacement therapy in men and menopause and estrogen replacement therapy in women. Supported by his experienced medical team, Dr. Nazarian treats men and women with hormone deficiencies and imbalances and enjoys the one-on-one relationship between patient and doctor.
HRT LA is the premier hormone therapy practice in Beverly Hills headed by the award-winning Dr. David Nazarain.
Copyright ©2025 Design & Developed by Freelancers Hub
